5 Fastest Growing Biotech Companies in the US

Page 5 of 5

1. Moderna, Inc. (NASDAQ: MRNA)

Headquarters: Cambridge, Massachusetts

No. of employees:  1,100

Revenue (2018): $135 million

Revenue (2019): $60 million

Topping our list of 15 fastest growing biotech companies in the US is Moderna, which is getting fame amid its successful COVID-19 vaccine. Founded in 2010, Moderna, Inc. is a biotechnology company that focuses on developing transformative drugs based on messenger ribonucleic acid (mRNA). Its drug development programs span cardiovascular diseases, immuno-oncology, infectious diseases, and rare diseases. It has an advanced pipeline of diverse programs among which 11 have joined clinical trials. Its clinical trials include mRNA-2416, mRNA-4157, mRNA-1893, and mRNA-1647 and among others.

Moderna’s COVID-19 vaccine, mRNA-1273, has shown an efficacy rate of 94.1% in the Pivotal Phase 3 Trial. On December 18, 2020, mRNA-1273 received emergency use authorization (EUA) from the U.S. FDA, making it the second authorized COVID-19 vaccine in the United States.

Baron Health Care Fund highlighted a few stocks in their Q4 2020 investor letter and Moderna Inc. (NASDAQ:MRNA) is one of them. Here is what Baron Health Care Fund said:

“Moderna, Inc. is a leader in the emerging field of mRNA-based vaccines and therapeutics. Shares pulled back from highs on likely profit taking, but we are looking past short-term fluctuations to focus on long-term potential. The pandemic has been a strong proof point of Moderna’s platform, with a COVID-19 vaccine coming to market in less than a year versus traditional vaccines that can take a decade. With this success under its belt, we think Moderna has potential to disrupt the entire biopharma space, from infectious disease vaccines to oncology and rare disease treatment.”

You can also take a peek at Top 10 Car Company Stocks to Invest In and Ray Dalio’s Top 10 Stock Picks for 2021.

Page 5 of 5